ReadYourDNA

Sertraline (Zoloft)

Raw research findings for this medication. Mostly single studies, not curated or confirmed robust.

About Sertraline

What it is

Sertraline is one of the most widely prescribed antidepressants, of the SSRI group: it keeps more of the messenger serotonin available between nerve cells. It is used for depression, panic disorder, social anxiety, obsessive-compulsive disorder, post-traumatic stress disorder and severe premenstrual symptoms. It is sold as Zoloft and Lustral, among other names.

How genes come into it

Sertraline is broken down by several liver enzymes, mainly CYP2C19 and CYP2B6. People with two low-function CYP2C19 copies (poor metabolizers) have clearly higher blood levels, and slower CYP2B6 versions raise them too. CPIC has published a guideline on CYP2C19 and CYP2B6 for sertraline, and DPWG on CYP2C19. Many studies have looked at serotonin genes such as HTR2A and SLC6A4 and at the transporter ABCB1 for how well it works, with weaker evidence.

Published guidelines

Clinical guidelines that name a gene for Sertraline. They sort people into groups by the gene copies they carry.

CPIC guideline: CYP2B6, CYP2C19. CYP2B6: Ultrarapid Metabolizer, Rapid Metabolizer, Normal Metabolizer, Intermediate Metabolizer, Poor Metabolizer, Indeterminate, No Result · CYP2C19: Ultrarapid Metabolizer, Rapid Metabolizer, Normal Metabolizer, Likely Intermediate Metabolizer, Intermediate Metabolizer, Likely Poor Metabolizer, Poor Metabolizer, Indeterminate, No Result. Strong. 2023.

DPWG guideline: CYP2C19. Ultrarapid Metabolizer · Normal Metabolizer · Intermediate Metabolizer · Poor Metabolizer. 2022.

What research found

Every published finding on gene variants and Sertraline. Upload your DNA file to see which of these rows apply to you.

Rated evidence (22 rated variants)

PharmGKB weighs all studies of a variant and rates how strong the evidence is, from 1A (strongest) to 4.

CYP2C19 CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17: Level 1A · replicated. Metabolism/PK: Mental Disorders. 6.

CYP2B6 CYP2B6*1, CYP2B6*4, CYP2B6*6, CYP2B6*9: Level 1A · replicated. Metabolism/PK. 4.

HTR1A rs6295: Level 3. Efficacy: Depressive Disorder, Major Depressive Disorder. 7.

ABCB1 rs2032583: Level 3. Efficacy: Depression, Depressive Disorder, Major Depressive Disorder. 3.

Metabolism (20 findings)

Studies of how quickly the body processes this medication.

CYP2B6 CYP2B6*1, CYP2B6*4: CYP2B6 *1/*4 + *4/*4 are associated with decreased concentrations of sertraline as compared to CYP2B6 *1/*1.

CYP2B6 CYP2B6*1, CYP2B6*6, CYP2B6*9: CYP2B6 *6 + *9 are associated with increased concentrations of sertraline as compared to CYP2B6 *1/*1.

CYP2B6 CYP2B6*1, CYP2B6*6, CYP2B6*9: CYP2B6 *6/*9 + *1/*6 + *6/*6 is associated with increased concentrations of sertraline in people with Depressive Disorder, Major as compared to CYP2B6 *1/*1.

CYP2B6 CYP2B6*1, CYP2B6*6, CYP2B6*9: CYP2B6 *6/*6 + *6/*9 (assigned as poor metabolizer phenotype) are associated with increased concentrations of sertraline as compared to CYP2B6 *1/*1.

Response (56 findings)

Studies of how well it worked in people carrying a variant.

ACE rs1799752: Genotype del/del is associated with increased response to sertraline in people with Depressive Disorder.

BDNF rs6265: Genotype CC is associated with increased clinical benefit to citalopram, escitalopram, fluoxetine or sertraline in people with Major Depressive Disorder as compared to genotypes CT + TT.

BDNF rs6265: Genotype CC is associated with increased clinical benefit to escitalopram, fluoxetine, paroxetine or sertraline in people with Major Depressive Disorder as compared to genotypes CT + TT.

BDNF rs6265: Genotype CC is associated with increased clinical benefit to citalopram, escitalopram, fluoxetine, fluvoxamine, paroxetine or sertraline in people with Major Depressive Disorder as compared to genotypes CT + TT.

Dosing (3 findings)

Studies of how much of the drug people needed or tolerated.

CYP2D6 CYP2D6*1, CYP2D6*4: CYP2D6 *4/*4 is associated with decreased dose of citalopram, escitalopram, fluoxetine, fluvoxamine, paroxetine or sertraline in people with Depression as compared to CYP2D6 *1/*1.

HTR2A rs6313: Genotypes AA + AG is associated with increased dose of sertraline in children with Depression or Anxiety Disorders as compared to genotype GG.

HTR2A rs7997012: Allele A is not associated with dose of sertraline in children with Depression or Anxiety Disorders as compared to allele G.

Side effects (3 findings)

Studies of side effects in people carrying a variant.

CYP2C19 CYP2C19*1, CYP2C19*17: CYP2C19 *1/*17 + *17/*17 (assigned as ultrarapid metabolizer phenotype) are not associated with response to citalopram, escitalopram or sertraline in women with Depression and Pregnancy as compared to CYP2C19 *1/*1 (assigned as normal metabolizer phenotype) .

CYP2C19 CYP2C19*1, CYP2C19*2, CYP2C19*17: CYP2C19 *1/*2 + *2/*17 + *2/*2 (assigned as intermediate metabolizer and poor metabolizer phenotype) are not associated with response to citalopram, escitalopram or sertraline in women with Depression and Pregnancy as compared to CYP2C19 *1/*1 (assigned as normal metabolizer phenotype) .

SLC6A4 SLC6A4 L allele-rs25531T: SLC6A4 L allele-rs25531T is not associated with time to response to sertraline in children with Depression or Anxiety Disorders.

Study findings and evidence levels: PharmGKB (CC BY-SA 4.0). Guidelines: CPIC and DPWG, as bundled in PharmCAT. Most studies were done mainly in people of European ancestry.

Related Drugs

More drugs from the same category

Celexa (SSRIs)

Lexapro (SSRIs)

Luvox (SSRIs)

Not a prescribing recommendation. This page is educational information about pharmacogenomic research and clinical guidelines - it is not medical or dosing advice, and not a prediction of how any medication will work for you. Never start, stop, or change a medication or dose based on it; talk to your doctor or pharmacist, who can order clinical-grade testing if appropriate.

Back to Medications

Content updated September 2026.

ReadYourDNA provides educational interpretation of DNA data you already have. It is not diagnostic, not a substitute for professional medical advice, diagnosis, or treatment, and is not intended to diagnose, treat, cure, or prevent any disease. Talk to a clinician before acting on any result.

Raw DNA Data Reports for 23andMe & AncestryDNA · About ReadYourDNA · FAQ · Methodology & Science · Pricing · Support and complaints · Legal & Contact · Health Traits · Pharmacogenomics · Carrier Status · Variant Explorer · The Human Karyotype · Privacy Policy · Terms of Service · Accessibility · Consumer Health Data Privacy · Your Privacy Choices · Editorial Standards · Your Data, Checkable · Sample Report · ReadYourDNA and Promethease compared · What is inside a 23andMe raw data file · What is inside an AncestryDNA raw data file · What a chatbot can and cannot do with your raw DNA file · Where a raw DNA file can still be uploaded in 2026

Written, maintained and operated by Martin Pechhacker, sole proprietor, Vienna, Austria. Trade register GISA 40064420. support@readyourdna.com